The S&P 500’s latest rebalance reveals how the index quietly upgrades itself by promoting winners like Carvana and CRH and removing underperformers through a process that more closely resembles disciplined...
Virginia-based Indivior, a developer of opioid addiction treatments, continues to hold down a place in Barchart’s Top 100 Stocks to Buy. Up 192% in 2025, its P/E is declining despite the stock’s gains...
RICHMOND, Va. , Dec. 22, 2025 /PRNewswire/ -- Indivior PLC (Nasdaq: INDV) (" Indivior PLC " or the " Company ") today announced that it will be added to the S&P SmallCap 600 ® index,...
RICHMOND, Va. , Dec. 17, 2025 /PRNewswire/ -- Indivior PLC (Nasdaq: INDV) today announced results from a randomized, double-blind clinical trial published in JAMA Network Open. The...
NEW YORK , Dec. 5, 2025 /PRNewswire/ -- S&P Dow Jones Indices ("S&PÂ DJI") will make the following changes to the S&P 500, S&P MidCap 400, and S&P SmallCap 600 indices effective prior to the open...
RICHMOND, Va. , Nov. 20, 2025 /PRNewswire/ --Â Indivior PLC (Nasdaq: INDV) today announced the Company has concluded the legacy U.S. Department of Justice (DOJ) matter by paying in full the outstanding...
RICHMOND, Va. , Nov. 19, 2025 /PRNewswire/ --Â Indivior PLC (NASDAQ: INDV) today announced that it will participate in the Piper Sandler 37 th Annual Healthcare Conference:
RICHMOND, Va. , Nov. 3, 2025 /PRNewswire/ -- Indivior PLC (Nasdaq: INDV) presented three new scientific posters at the Academy of Managed Care Pharmacy (AMCP) Nexus 2025 conference last week,...
RICHMOND, Va. , Oct. 30, 2025 /PRNewswire/ -- Indivior PLC (Nasdaq: INDV) today reported its financial results for the third quarter ended September 30, 2025, and provided a business update.
RICHMOND, Va. , Oct. 28, 2025 /PRNewswire/ --Â Indivior PLC (NASDAQ: INDV) today announced that it will participate in the Stifel 2025 Healthcare Conference: